Immune System News and Research

RSS

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases.

16 Mar 2022

Study finds a promising new target for immunity-boosting cancer treatments

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.

16 Mar 2022

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Some "hypervirulent" strains of Listeria monocytogenes have a greater capacity to infect the central nervous system.

16 Mar 2022

Tracking the mutating coronavirus variants

Viruses continuously and naturally evolve. To track coronavirus variants, we need to think like Darwin.

16 Mar 2022

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Children who develop type 1 diabetes show epigenetic changes in the cells of their immune system already before the antibodies of the disease are detected in their blood.

16 Mar 2022

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Long term exposure to air pollution is linked to a heightened risk of autoimmune disease, particularly rheumatoid arthritis, connective tissue and inflammatory bowel diseases, finds research published online in the open access journal RMD Open.

16 Mar 2022

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

Since the very beginning of the pandemic, there has been concern about the emergence of Guillain-Barré syndrome, a rare disorder where the body's immune system damages nerves. In some cases, nerve damage causes muscle weakness and paralysis.

16 Mar 2022

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

Adequate glycemic control during the year after being vaccinated against the SARS-CoV-2 improves the relative immunological response.

15 Mar 2022

Immune cells could help predict the prognosis of patients with ALS

Immune cells could help predict the prognosis of patients with the rare neurological disease amyotrophic lateral sclerosis (ALS), says a study published today in eLife.

15 Mar 2022

Researchers identify a potential new test for early diagnosis of Lyme disease

For scientists and clinicians alike, one of the Holy Grails for successfully treating and curing Lyme disease is developing tests that identify the disease sooner, show when people are cured of infection, and can diagnose reinfection.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022

Study finds elevated inflammation in macrophages months after mild COVID-19

There is a lack of understanding as to why some people suffer from long-lasting symptoms after COVID-19 infection.

15 Mar 2022

Moderate hyperglycemia associated with poor COVID-19 prognosis

Scientists have revealed that non-diabetic patients with moderate hyperglycemia are more likely to develop severe and fatal COVID-19 than diabetic patients.

15 Mar 2022

SARS-CoV-2 in diabetes pathogenesis

Researchers reviewed the causes of diabetes mellitus, focusing on respiratory viruses, including influenza virus and SARS-CoV-2.

15 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

14 Mar 2022

Immune System News and Research

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

Study finds a promising new target for immunity-boosting cancer treatments

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Tracking the mutating coronavirus variants

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

Immune cells could help predict the prognosis of patients with ALS

Researchers identify a potential new test for early diagnosis of Lyme disease

High doses of antibiotic may safely and effectively treat TB meningitis

Study finds elevated inflammation in macrophages months after mild COVID-19

Moderate hyperglycemia associated with poor COVID-19 prognosis

SARS-CoV-2 in diabetes pathogenesis

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

New approach to send ‘friendly’ nano-particles into the body shows promising results

Researchers develop a system of synthetic biosensors to assess the response of cancer therapy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News